Business StandardCenter·
Glenmark Pharma Q2FY27 results: Net profit falls 57% to ₹264 crore
Consolidated revenue declined 29.8 per cent to ₹4,247 crore from ₹6,047 crore in Q2FY26
Read at Business Standard →
Consolidated revenue declined 29.8 per cent to ₹4,247 crore from ₹6,047 crore in Q2FY26

<iframe src="https://hindustansphere.com/embed/cluster/5b9b5613f20afa101bf1767ea76f4786c474a0f1" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Glenmark Pharma Q2FY27 results: Net profit falls 57% to ₹264 crore"></iframe>
